Drugs / ET-970
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT07645690 | Jul 2026 → Dec 2027 expected | clear cell renal carcinoma | Chinese PLA General Hospital | Recruiting | No outcome recorded |
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ET-970 | “CLEAR CAR-T cell injection (ET-970) is an engineered CD70-targeting allogeneic Chimeric Antigen Receptor T-Cell (CAR-T cell).” NCT07645690 ↗ |
| Known as | CLEAR CAR-T cell injection | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07645690 ↗ |
| Modality | Cell therapy | “CAR-T cell” NCT07645690 ↗ |
| Route | Intravenous | “Administered by IV infusion” NCT07645690 ↗ |
| Target | CD70 | “CD70-targeting” NCT07645690 ↗ |